TrialPanorama/TrialPanorama-database huggingface dataset:
Study 24242823 — Surrogate Endpoint (SUR): Blood pressure
Study 24242861 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 24242861 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 24243422 — Surrogate Endpoint (SUR): Serum triglycerides
Study 24244090 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 24244090 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 24245549 — Predictive Biomarker (PRD): GSTA1 mRNA
Genes: GSTA1
Study 24245549 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 24245549 — Predictive Biomarker (PRD): CEMIP mRNA
Genes: CEMIP; KIAA1199
Study 24246622 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24248942 — Surrogate Endpoint (SUR): Blood pressure
Study 24249802 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 24249967 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 24251951 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 24252049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24252402 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24252402 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 24257514 — Surrogate Endpoint (SUR): Blood pressure
Study 24259241 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 24260259 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 24260259 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 24261996 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24262504 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 24263064 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24265415 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24265670 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24265670 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 24265670 — Predictive Biomarker (PRD): KLF2 mRNA
Genes: KLF2; LKLF
Study 24265670 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 24265828 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 24268783 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 24269266 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 24269855 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 24271095 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24273046 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24273046 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24273046 — Predictive Biomarker (PRD): Hormone receptor
Study 24274658 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 24275629 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 24275804 — Surrogate Endpoint (SUR): Serum creatinine
Study 24276017 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 24276017 — Safety Biomarker (SAF): BDNF
Study 24277073 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 24281137 — Surrogate Endpoint (SUR): Blood pressure
Study 24281330 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 24282316 — Surrogate Endpoint (SUR): Blood pressure
Study 24283202 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 24283202 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 24283216 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 24283216 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 24284413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24284865 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 24285681 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 24285681 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study 24288021 — Surrogate Endpoint (SUR): Blood pressure
Study 24290615 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24292639 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 24292957 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 24294924 — Safety Biomarker (SAF): Reactive oxygen species
Study 24295986 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 24297161 — Predictive Biomarker (PRD): GSTZ1 mRNA
Genes: GSTZ1; MAAI
Study 24297771 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 24303954 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24304654 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 24304654 — Surrogate Endpoint (SUR): Blood pressure
Study 24305645 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 24307008 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 24307220 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 24308791 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24308791 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 24308871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24309189 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 24309956 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 24309981 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24309981 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study 24309981 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24311637 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 24311704 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 24314292 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 24314292 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 24314292 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 24314292 — Safety Biomarker (SAF): Th2 cell
Study 24314307 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24314307 — Surrogate Endpoint (SUR): Pathological complete response
Study 24314346 — Predictive Biomarker (PRD): GATA4 mRNA
Genes: GATA4
Study 24314346 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 24315509 — Surrogate Endpoint (SUR): Blood pressure
Study 24315509 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24315509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24319018 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 24321746 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 24321803 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 24321803 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24321803 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24323026 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 24323026 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24324590 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study 24326155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24327334 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24329107 — Predictive Biomarker (PRD): SPINK5 mRNA
Genes: SPINK5
Study 24329122 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 24329524 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 24330454 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 24332189 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24332215 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 24332241 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 24332512 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 24335103 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24335498 — Predictive Biomarker (PRD): SMC1A mRNA
Genes: SMC1A; DXS423E; KIAA0178; SB1.8; SMC1; SMC1L1
Study 24335498 — Predictive Biomarker (PRD): SMC3 mRNA
Genes: SMC3; BAM; BMH; CSPG6; SMC3L1
Study 24335498 — Predictive Biomarker (PRD): RAD21 mRNA
Genes: RAD21; HR21; KIAA0078; NXP1; SCC1
Study 24335498 — Predictive Biomarker (PRD): BAALC mRNA
Genes: BAALC
Study 24335884 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24344220 — Predictive Biomarker (PRD): PSMB9 mRNA
Genes: PSMB9; LMP2; PSMB6i; RING12
Study 24345402 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24345402 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24345751 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 24345751 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24347518 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24349052 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 24349334 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 24349470 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24349470 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24351336 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 24351336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24351336 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 24351877 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 24352251 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 24352795 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 24354947 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study 24355487 — Predictive Biomarker (PRD): Hormone receptor
Study 24355824 — Surrogate Endpoint (SUR): Blood pressure
Study 24356628 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 24359243 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 24361682 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24362550 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 24365086 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24365086 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 24365086 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 24365862 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 24365862 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study 24365862 — Safety Biomarker (SAF): Interleukin 12
Study 24365862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24365862 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 24367599 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24367599 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 24369412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24370210 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24370210 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24370210 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24373343 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 24373343 — Monitoring Biomarker (MOI): Alpha-1-acid glycoprotein 1
Genes: ORM1; AGP1
Study 24373343 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 24373343 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study 24373343 — Predictive Biomarker (PRD): IGFBP1 mRNA
Genes: IGFBP1; IBP1
Study 24373343 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study 24373343 — Predictive Biomarker (PRD): IGFBP4 mRNA
Genes: IGFBP4; IBP4
Study 24375324 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 24376516 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 24377099 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 24377099 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 24379526 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 24379526 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 24379526 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 24381190 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24381226 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study 24381750 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24383474 — Predictive Biomarker (PRD): SNRPF mRNA
Genes: SNRPF; PBSCF
Study 24383474 — Predictive Biomarker (PRD): PPT2 mRNA
Genes: PPT2
Study 24383474 — Predictive Biomarker (PRD): MAN2B1 mRNA
Genes: MAN2B1; LAMAN; MANB
Study 24383474 — Predictive Biomarker (PRD): MGAT5B mRNA
Genes: MGAT5B; KIAA2008
Study 24383474 — Predictive Biomarker (PRD): MAN1C1 mRNA
Genes: MAN1C1; MAN1A3; MAN1C
Study 24383664 — Surrogate Endpoint (SUR): Sperm parameters
Study 24384417 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24384417 — Surrogate Endpoint (SUR): Serum creatinine
Study 24385516 — Surrogate Endpoint (SUR): Urinary oxalate
Study 24386229 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24386300 — Predictive Biomarker (PRD): SFTPB mRNA
Genes: SFTPB; SFTP3
Study 24386300 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study 24386300 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 24388161 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 24389297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24396625 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24396625 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 24396625 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24396625 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 24398331 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 24398331 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24398331 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 24400847 — Surrogate Endpoint (SUR): Blood pressure
Study 24406779 — Surrogate Endpoint (SUR): Blood pressure
Study 24407191 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 24410126 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 24410943 — Surrogate Endpoint (SUR): Blood pressure
Study 24414130 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24414130 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24416138 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 24416138 — Predictive Biomarker (PRD): PDGFRA
Genes: CD140a; PDGFR2; GAS9
Study 24417980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24418731 — Surrogate Endpoint (SUR): Blood pressure
Study 24419411 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24420643 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24420643 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 24420643 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 24420643 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 24420643 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study 24420643 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 24420643 — Surrogate Endpoint (SUR): Bone mineral density
Study 24422672 — Predictive Biomarker (PRD): KIAA1549 mRNA
Genes: KIAA1549
Study 24422672 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24422672 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 24422672 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 24422782 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 24423045 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 24423476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24423745 — Surrogate Endpoint (SUR): Bone mineral density
Study 24429311 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24429337 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24430093 — Surrogate Endpoint (SUR): Bone mineral density
Study 24431228 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 24431909 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study 24433481 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study 24433481 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study 24435003 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24436111 — Predictive Biomarker (PRD): ATP1A3 mRNA
Genes: ATP1A3
Study 24438342 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24438342 — Surrogate Endpoint (SUR): Blood pressure
Study 24439297 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 24440112 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24440279 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24443277 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 24444339 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 24444339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24445353 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 24445353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24446519 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24446656 — Predictive Biomarker (PRD): GIPR mRNA
Genes: GIPR
Study 24446656 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 24446656 — Surrogate Endpoint (SUR): Bone mineral density
Study 24446658 — Surrogate Endpoint (SUR): Bone mineral density
Study 24452746 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 24452753 — Predictive Biomarker (PRD): Liver iron
Study 24456358 — Safety Biomarker (SAF): Reactive oxygen species
Study 24456358 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24456695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24457244 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study 24457379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24457379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24458353 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 24458953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24458953 — Surrogate Endpoint (SUR): Blood pressure
Study 24458953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24458953 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 24459219 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study 24459612 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24459612 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 24460746 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 24461715 — Surrogate Endpoint (SUR): Blood pressure
Study 24463454 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 24464121 — Safety Biomarker (SAF): Hyaluronic acid
Study 24464355 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 24464355 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24464597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 24464944 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 24465572 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24467603 — Predictive Biomarker (PRD): PTGES2 mRNA
Genes: PTGES2; C9orf15; PGES2
Study 24467603 — Predictive Biomarker (PRD): PTGER4 mRNA
Genes: PTGER4; PTGER2
Study 24467979 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 24470004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24470004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24470398 — Surrogate Endpoint (SUR): Total kidney volume
Study 24472814 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 24472814 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 24472814 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24474568 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 24475922 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2